[{"address1": "100 Campus Drive", "city": "Florham Park", "state": "NJ", "zip": "07932", "country": "United States", "phone": "608 441 8120", "website": "https://www.cellectar.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study for patients with B-cell malignancies; Phase 2a clinical study for patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia cohort, r/r multiple myeloma (MM) cohort, and r/r non-Hodgkin's lymphoma cohort; Phase 1 clinical study for r/r pediatric patients with select solid tumors, lymphomas, and malignant brain tumors; and Phase 1 clinical study for r/r head and neck cancer. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChemBio. The company was founded in 2002 and is headquartered in Florham Park, New Jersey.", "fullTimeEmployees": 20, "companyOfficers": [{"maxAge": 1, "name": "Mr. James V. Caruso", "age": 65, "title": "President, CEO & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 650000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chad J. Kolean CPA", "age": 60, "title": "VP, CFO & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 425000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jarrod  Longcor", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 500000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 4, "previousClose": 0.281, "open": 0.2781, "dayLow": 0.275, "dayHigh": 0.2977, "regularMarketPreviousClose": 0.281, "regularMarketOpen": 0.2781, "regularMarketDayLow": 0.275, "regularMarketDayHigh": 0.2977, "beta": 1.048, "forwardPE": -0.42608058, "volume": 797538, "regularMarketVolume": 797538, "averageVolume": 2854620, "averageVolume10days": 1625230, "averageDailyVolume10Day": 1625230, "bid": 0.2059, "ask": 0.3615, "bidSize": 200, "askSize": 200, "marketCap": 13400035, "fiftyTwoWeekLow": 0.22, "fiftyTwoWeekHigh": 4.45, "fiftyDayAverage": 0.4338, "twoHundredDayAverage": 1.8997, "currency": "USD", "enterpriseValue": -5353026, "floatShares": 45326470, "sharesOutstanding": 46079900, "sharesShort": 2355367, "sharesShortPriorMonth": 1882803, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0511, "heldPercentInsiders": 0.01644, "heldPercentInstitutions": 0.11062, "shortRatio": 0.99, "shortPercentOfFloat": 0.0563, "impliedSharesOutstanding": 46079900, "bookValue": 0.038, "priceToBook": 7.6526318, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -50107196, "trailingEps": -1.41, "forwardEps": -2.83, "lastSplitFactor": "1:10", "lastSplitDate": 1658448000, "enterpriseToEbitda": 0.104, "52WeekChange": -0.9148936, "SandP52WeekChange": 0.22903383, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CLRB", "underlyingSymbol": "CLRB", "shortName": "Cellectar Biosciences, Inc.", "longName": "Cellectar Biosciences, Inc.", "firstTradeDateEpochUtc": 1131633000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "d92a6d57-8c29-3e38-89dc-584b57cac7f0", "messageBoardId": "finmb_37613299", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.2908, "targetHighPrice": 13.0, "targetLowPrice": 1.0, "targetMeanPrice": 5.66667, "targetMedianPrice": 3.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 34263372, "totalCashPerShare": 0.744, "ebitda": -51287708, "totalDebt": 512750, "quickRatio": 1.687, "currentRatio": 1.767, "debtToEquity": 3.099, "returnOnAssets": -1.09571, "returnOnEquity": -4.74632, "freeCashflow": -25075868, "operatingCashflow": -46265224, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]